<DOC>
	<DOC>NCT02478983</DOC>
	<brief_summary>The investigators conduct this study to evaluate the clinical efficacy of size 1 and 1.5 supreme LMA compared to proseal LMA for infants weighing &lt;10kg.</brief_summary>
	<brief_title>A Randomized Comparison of LMA (Laryngeal Mask Airway) Supreme and LMA Proseal in Infants Below 10kg</brief_title>
	<detailed_description>This is a randomized prospective study to compare the clinical efficacy and safety for size 1 and 1.5 LMA supreme and LMA Proseal. The airway leak pressure of these 2 devices will be compared and other parameters such as time to insertion, insertion success rate, fibreoptic glottic view and intraoperative complications will be recorded.</detailed_description>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>Weight of &lt; 10kg ASA (American Society of Anesthesiologists) III Infants undergoing elective surgery under general anaesthesia using supraglottic airway device. Informed consent obtained from parents. ASA IIIIV and emergency surgery Neonates and expremature babies with post conceptual age &lt;55 weeks. Infants with history of difficult airway. Infants with features of difficult intubation. Active upper respiratory tract infection Infants with pulmonary disease Infants with history of gastroesophageal reflux disease Infants with risks of regurgitation and aspiration.</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>